Search Results - Peter Mullen
- Showing 1 - 6 results of 6
-
1
-
2
A phosphoramidate modification of FUDR, NUC-3373, causes DNA damage and DAMPs release from colorectal cancer cells, potentiating lymphocyte-induced cell death by Oliver J. Read, Jennifer Bré, Ying Zhang, Peter Mullen, Mustafa Elshani, David J. Harrison
Published in PLoS ONE (2025-01-01)Get full text
Article -
3
A phosphoramidate modification of FUDR, NUC-3373, causes DNA damage and DAMPs release from colorectal cancer cells, potentiating lymphocyte-induced cell death. by Oliver J Read, Jennifer Bré, Ying Zhang, Peter Mullen, Mustafa Elshani, David J Harrison
Published in PLoS ONE (2025-01-01)Get full text
Article -
4
Kidney tumoroid characterisation by spatial mass spectrometry with same-section multiplex immunofluorescence uncovers tumour microenvironment lipid signatures associated with aggre... by Hazem Abdullah, Greice M. Zickuhr, In Hwa Um, Alexander Laird, Peter Mullen, David J. Harrison, Alison L. Dickson
Published in npj Imaging (2025-09-01)Get full text
Article -
5
-
6
Defining the mode of action of cisplatin combined with NUC-1031, a phosphoramidate modification of gemcitabine by Dillum Patel, Alison L. Dickson, Greice M. Zickuhr, In Hwa Um, Oliver J. Read, Clarissa M. Czekster, Peter Mullen, David J. Harrison, Jennifer Bré
Published in Translational Oncology (2024-12-01)Get full text
Article
